Evidence map›Paper›PMID 34316671›Full record

ArticleClinical parkinsonism & related disorders2021

Video-based Parkinson's disease assessments in a nationwide cohort of Fox Insight participants.

Taylor L Myers, Christopher G Tarolli, Jamie L Adams, Richard Barbano, María Cristina Gil-Díaz, Kelsey L Spear, Jill Lowell, Margaret Daeschler, Lindsey Riley, Ninad Amondikar and 5 more

Open access · goldAbstract read
In one paragraph

Article in Clinical parkinsonism & related disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Televisits for Parkinson's disease: benefits and barriers.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic Modifiers of Parkinson's Disease: A Case-Control Study.Annals of clinical and translational neurology · 2025
    Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Taylor L MyersCenter for Health + Technology, University of Rochester, 265 Crittenden Blvd, Rochester, NY 14642, USA.
Christopher G TarolliCenter for Health + Technology, University of Rochester, 265 Crittenden Blvd, Rochester, NY 14642, USA.
Jamie L AdamsCenter for Health + Technology, University of Rochester, 265 Crittenden Blvd, Rochester, NY 14642, USA.
Richard BarbanoDepartment of Neurology, University of Rochester, 601 Elmwood Ave. Rochester, NY 14642, USA.
María Cristina Gil-DíazUniversity of Rochester, 500 Joseph C. Wilson Blvd., Rochester, NY 14627, USA.
Kelsey L SpearCenter for Health + Technology, University of Rochester, 265 Crittenden Blvd, Rochester, NY 14642, USA.
Jill LowellDepartment of Neurology, University of Rochester, 601 Elmwood Ave. Rochester, NY 14642, USA.
Margaret DaeschlerMichael J. Fox Foundation for Parkinson's Research, PO Box 4777, New York, NY 10163, USA.
Lindsey RileyMichael J. Fox Foundation for Parkinson's Research, PO Box 4777, New York, NY 10163, USA.
Ninad AmondikarMichael J. Fox Foundation for Parkinson's Research, PO Box 4777, New York, NY 10163, USA.
Peggy AuingerCenter for Health + Technology, University of Rochester, 265 Crittenden Blvd, Rochester, NY 14642, USA.
Connie MarrasDepartment of Neurology, University of Toronto, 6 Queen's Park Crescent West, Toronto, ON M5S 3H2, Canada.
Caroline M TannerDepartment of Neurology, University of California San Francisco, 400 Parnassus Ave Eighth Floor, San Francisco, CA 94143, USA.
E Ray DorseyCenter for Health + Technology, University of Rochester, 265 Crittenden Blvd, Rochester, NY 14642, USA.
Ruth B SchneiderCenter for Health + Technology, University of Rochester, 265 Crittenden Blvd, Rochester, NY 14642, USA.
University of Rochester · USMichael J. Fox Foundation · USUniversity of California, San Francisco · USUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionParkinson's disease (PD) research is hampered by slow, inefficient recruitment and burdensome in-person assessments that may be challenging to conduct in a world affected by COVID-19. Fox Insight is an ongoing prospective clinical research study that enables individuals to participate in clinical research from their own homes by completing online questionnaires. To date, over 45,000 participants with and without PD have enrolled. We sought to validate self-reported PD diagnosis in the Fox Insight cohort, assess the validity of other self-reported health information, and evaluate the willingness of participants to participate in video-based research studies.

methodsIndividuals with and without self-reported PD enrolled in Fox Insight were invited to participate in this virtual research study. Participants completed online questionnaires and two virtual visits, during which we conducted standard cognitive and motor assessments. A movement disorder expert determined the most likely diagnosis, which was compared to self-reported diagnosis.

resultsA total of 203 participants from 40 U.S. states, 159 with remote clinician-determined PD and 44 without, completed the study (59% male, mean (SD) age 65.7 (9.8)). Level of agreement between self-reported PD diagnosis in Fox Insight and clinician-determined diagnosis was very good ((kappa = 0.85, 95% CI 0.76-0.94). Overall, 97.9% of participants were satisfied with the study, 98.5% were willing to participate in a future observational study with virtual visits, and 76.1% were willing to participate in an interventional trial with virtual visits.

conclusionAmong the Fox Insight cohort, self-reported diagnosis is accurate and interest in virtual research studies is high.

Indexed as

Fox InsightParkinson’s diseaseTelemedicineVideo-based

Identifiers

PMID34316671
PMCPMC8299965
OpenAlexW3165543997

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.